Entry
Name
MicroRNAs in cancer - Mus musculus (house mouse)
Description
MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.
Class
Human Diseases; Cancer: overview
BRITE hierarchy
Pathway map
Ortholog table
Organism
Mus musculus (house mouse) [GN:
mmu ]
Gene
12576 Cdkn1b; cyclin dependent kinase inhibitor 1B [KO:K06624 ]
21859 Timp3; tissue inhibitor of metalloproteinase 3 [KO:K16866 ]
16653 Kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827 ]
12928 Crk; v-crk avian sarcoma virus CT10 oncogene homolog [KO:K04438 ]
12929 Crkl; v-crk avian sarcoma virus CT10 oncogene homolog-like [KO:K04438 ]
17210 Mcl1; myeloid cell leukemia sequence 1 [KO:K02539 ]
22339 Vegfa; vascular endothelial growth factor A [KO:K05448 ]
21417 Zeb1; zinc finger E-box binding homeobox 1 [KO:K09299 ]
21808 Tgfb2; transforming growth factor, beta 2 [KO:K13376 ]
24064 Spry2; sprouty RTK signaling antagonist 2 [KO:K17383 ]
20724 Serpinb5; serine (or cysteine) peptidase inhibitor, clade B, member 5 [KO:K10139 ]
74370 Rptor; regulatory associated protein of MTOR, complex 1 [KO:K07204 ]
22061 Trp63; transformation related protein 63 [KO:K10149 ]
24136 Zeb2; zinc finger E-box binding homeobox 2 [KO:K23560 ]
14086 Fscn1; fascin actin-bundling protein 1 [KO:K23551 ]
56289 Rassf1; Ras association (RalGDS/AF-6) domain family member 1 [KO:K09850 ]
74747 Ddit4; DNA-damage-inducible transcript 4 [KO:K08270 ]
11987 Slc7a1; solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 [KO:K13863 ]
20848 Stat3; signal transducer and activator of transcription 3 [KO:K04692 ]
15461 Hras; Harvey rat sarcoma virus oncogene [KO:K02833 ]
11789 Apc; APC, WNT signaling pathway regulator [KO:K02085 ]
23805 Apc2; APC regulator of WNT signaling pathway 2 [KO:K02085 ]
18709 Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649 ]
18708 Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649 ]
18710 Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649 ]
18706 Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922 ] [EC:2.7.1.153 ]
18707 Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922 ] [EC:2.7.1.153 ]
74769 Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922 ] [EC:2.7.1.153 ]
15387 Hnrnpk; heterogeneous nuclear ribonucleoprotein K [KO:K12886 ]
53614 Reck; reversion-inducing-cysteine-rich protein with kazal motifs [KO:K17461 ]
12151 Bmi1; Bmi1 polycomb ring finger oncogene [KO:K11459 ]
17389 Mmp16; matrix metallopeptidase 16 [KO:K07996 ] [EC:3.4.24.-]
12703 Socs1; suppressor of cytokine signaling 1 [KO:K04694 ]
192119 Dicer1; dicer 1, ribonuclease type III [KO:K11592 ] [EC:3.1.26.-]
16402 Itga5; integrin alpha 5 (fibronectin receptor alpha) [KO:K06484 ]
67653 4930544G11Rik; RIKEN cDNA 4930544G11 gene [KO:K04513 ]
22762 Zfpm2; zinc finger protein, multitype 2 [KO:K17442 ]
22196 Ube2i; ubiquitin-conjugating enzyme E2I [KO:K10577 ]
20677 Sox4; SRY (sex determining region Y)-box 4 [KO:K23581 ]
12575 Cdkn1a; cyclin dependent kinase inhibitor 1A [KO:K06625 ]
140486 Igf2bp1; insulin-like growth factor 2 mRNA binding protein 1 [KO:K17391 ]
18033 Nfkb1; nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 [KO:K02580 ]
14784 Grb2; growth factor receptor bound protein 2 [KO:K04364 ]
22059 Trp53; transformation related protein 53 [KO:K04451 ]
17248 Mdm4; transformed mouse 3T3 cell double minute 4 [KO:K10127 ]
18595 Pdgfra; platelet derived growth factor receptor, alpha polypeptide [KO:K04363 ] [EC:2.7.10.1 ]
20662 Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099 ]
20663 Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099 ]
20416 Shc1; src homology 2 domain-containing transforming protein C1 [KO:K06279 ]
18590 Pdgfa; platelet derived growth factor, alpha [KO:K04359 ]
271849 Shc4; SHC (Src homology 2 domain containing) family, member 4 [KO:K17449 ]
18591 Pdgfb; platelet derived growth factor, B polypeptide [KO:K17386 ]
18596 Pdgfrb; platelet derived growth factor receptor, beta polypeptide [KO:K05089 ] [EC:2.7.10.1 ]
12578 Cdkn2a; cyclin dependent kinase inhibitor 2A [KO:K06621 ]
17118 Marcks; myristoylated alanine rich protein kinase C substrate [KO:K12561 ]
22415 Wnt3; wingless-type MMTV integration site family, member 3 [KO:K00312 ]
22416 Wnt3a; wingless-type MMTV integration site family, member 3A [KO:K00312 ]
67849 Cdca5; cell division cycle associated 5 [KO:K17390 ]
212980 Slc45a3; solute carrier family 45, member 3 [KO:K15379 ]
Reference
Authors
Lee YS, Dutta A
Title
MicroRNAs in cancer.
Journal
Reference
Authors
Babashah S, Soleimani M
Title
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
Journal
Reference
Authors
Garzon R, Calin GA, Croce CM
Title
MicroRNAs in Cancer.
Journal
Reference
Authors
Chen PS, Su JL, Hung MC
Title
Dysregulation of microRNAs in cancer.
Journal
Reference
Authors
Ling H, Zhang W, Calin GA
Title
Principles of microRNA involvement in human cancers.
Journal
Reference
Authors
Iorio MV, Croce CM
Title
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.
Journal
Reference
Authors
Sayed D, Abdellatif M
Title
MicroRNAs in development and disease.
Journal
Reference
Authors
Wang Q, Wang S, Wang H, Li P, Ma Z
Title
MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
Journal
Reference
Authors
Song JH, Meltzer SJ
Title
MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Journal
Reference
Authors
Chu Y, Zhu H, Lv L, Zhou Y, Huo J
Title
MiRNA s in oesophageal squamous cancer.
Journal
Neth J Med 71:69-75 (2013)
Reference
Authors
Kan T, Meltzer SJ
Title
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Journal
Reference
Authors
Smith CM, Watson DI, Michael MZ, Hussey DJ
Title
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Journal
Reference
Authors
Song S, Ajani JA
Title
The role of microRNAs in cancers of the upper gastrointestinal tract.
Journal
Reference
Authors
Liu WH, Yeh SH, Chen PJ
Title
Role of microRNAs in hepatitis B virus replication and pathogenesis.
Journal
Reference
Authors
Hrasovec S, Glavac D
Title
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
Journal
Reference
Authors
Liu H
Title
MicroRNAs in breast cancer initiation and progression.
Journal
Reference
Authors
Li SD, Zhang JR, Wang YQ, Wan XP
Title
The role of microRNAs in ovarian cancer initiation and progression.
Journal
Reference
Authors
Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA
Title
Characteristic patterns of microRNA expression in human bladder cancer.
Journal
Reference
Authors
Saini S, Majid S, Dahiya R
Title
Diet, microRNAs and prostate cancer.
Journal
Related pathway
KO pathway